AACE e-ECE clinical data previously presented at Endocrine Society’s 2021 annual meeting
NEEDHAM, Mass., May 20, 2021 (GLOBE NEWSWIRE) Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases currently treated with burdensome and painful injections, today announced that it will virtually present encore data from its MPOWERED™ Phase 3 clinical trial at the 23
rd European Congress of Endocrinology (e-ECE) (May 22-26, 2021) and new data from the MPOWERED trial at the 30
th Annual American Association of Clinical Endocrinology (AACE) Meeting (May 26-29, 2021).
Chiasma to Present Encore and New Data from MPOWERED™ Phase 3 Trial at Upcoming e-ECE and AACE Virtual Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BeiGene (BGNE) Highlights Progress in Hematology at EHA2021 Virtual Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Longtime OHS Canada columnist Alan Quilley dies after struggle with cancer April 26, 2021
OHS Canada, was the president of Safety Results, a consultancy and training service in Sherwood Park, Alta.
According to his obituary, occupational health and safety was a lifelong passion for Quilley. He authored several textbooks and delivered training courses to many future CRSPs over the course of his career.
A private ceremony will be held June 3 at Evergreen Memorial Gardens in Edmonton.
Advertisment
OHS Canada editor Marcel Vander Wier. “He will be greatly missed.”
“From the entire team at
OHS Canada, our condolences to his family and friends.”